Profluent Secures $35M in Additional Funding and Key Industry Experts to Scale Foundational AI Models for Biomedicine and Tackle First Vertical in Gene Editing
Profluent, an AI-first protein design company, today announced the close of additional funding to bring the total raised to $44M.
- Profluent, an AI-first protein design company, today announced the close of additional funding to bring the total raised to $44M.
- “Our research at the forefront of AI has enabled Profluent to create large language models that begin to learn the blueprint of nature,” said Ali Madani, Profluent co-founder and Chief Executive Officer.
- By first applying its platform to gene editing, the company showcases AI as the ideal interface for engineering complex biological systems.
- Just as ChatGPT can write compelling essays and emails, Profluent has developed AI that designs entirely new and functional proteins.